Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000934
Chunk: 61

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 61
---
24 hours prior to any release,
issuance, filing or use by the Company thereof.

(j) . Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to
consummate and make effective, as soon as reasonably possible, the Commencement, and to carry out the intent and accomplish the purposes
of this Agreement and the consummation of the transactions contemplated hereby.

(k) .

(l) . The language used in this Agreement will be deemed to be the language chosen by the parties to express their
mutual intent, and no rules of strict construction will be applied against any party. In addition, each and every reference to share prices
and Depositary Shares in this Agreement shall be subject to adjustment as provided in this Agreement for reverse and forward share splits,
Depositary Share-Ordinary Share ratio changes, share dividends, share combinations and other similar transactions of the Ordinary Shares
or Depositary Shares that occur after the date of this Agreement.

| -34- |

(m) . The Investor’s remedies provided in this Agreement, including, without limitation,
the Investor’s remedies provided in Section 9, shall be cumulative and in addition to all other remedies available to the Investor
under this Agreement, at law or in equity (including a decree of specific performance and/or other injunctive relief), no remedy of the
Investor contained herein shall be deemed a waiver of compliance with the provisions giving rise to such remedy and nothing herein shall
limit the Investor’s right to pursue actual damages for any failure by the Company to comply with the terms of this Agreement. The
Company and Investor each acknowledge that a breach by either of it of its respective obligations hereunder will cause irreparable harm
to the Company or Investor, as applicable, and that the remedy at law for any such breach may be inadequate. The Company and Investor
each therefore agree that, in the event of any such breach or threatened breach by the other party, the Company, on the one hand, and
the Investor, on the other hand, shall be entitled, in addition to all other available remedies, to an injunction restraining any breach,
without the necessity of showing economic loss and without any bond or other security being required, this being in addition to any other
remedy to which either party may be entitled by law or equity.

(n) . In the event that (